Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Stoughton, Massachusetts
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Virginia
- Filings on record
- 870 filings
- On EDGAR
- CIK 1267565
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 49
News 8 of 125
- 8-K Quarterly results Nov 5, 2026
- 8-K Current report on a material event Oct 19, 2026
- 8-K Other events Aug 13, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K/A Current report on a material event, amended Jun 30, 2026
- 8-K Shareholder vote results May 15, 2026
- 8-K Leadership change May 12, 2026
- 8-K Quarterly results May 7, 2026
Prospectuses and Registrations 8 of 39
- S-8 Registration statement for an employee plan Jun 1, 2026
- S-8 Registration statement for an employee plan Jun 1, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jun 6, 2025
Proxies 8 of 23
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2026
- DEFA14A Extra proxy material Mar 28, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2025
- DEFA14A Extra proxy material May 10, 2024
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2023
- DEFA14A Extra proxy material Apr 6, 2022
Ownership 8 of 586
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 30, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 29, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 8, 2026
- 144 Notice of a proposed sale of restricted stock Sep 30, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 24, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
Other 8 of 48
- ARS Annual report sent to shareholders Apr 7, 2026
- ARS Annual report sent to shareholders Mar 28, 2025
- ARS Annual report sent to shareholders Apr 5, 2024
- ARS Annual report sent to shareholders Apr 11, 2023
- SC TO-T/A Amended filing Mar 21, 2022
- SC TO-T/A Amended filing Mar 11, 2022
- SC TO-T/A Amended filing Mar 4, 2022
- SC TO-T/A Amended filing Feb 22, 2022
Everything here comes from Collegium Pharmaceutical, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.